All Insights
Showing 217 - 228 of 400
Regulatory and compliance
UK NHS suppliers required to commit to net zero by 2050 or lose out on future contract opportunities
From April, bidders for NHS contracts over £5 million must produce a carbon reduction plan
Commercial
Enforcement risks mount in Germany for comparison and intermediary platforms
German watchdog is pursuing misleading behaviour and lack of transparency on ranking, reviews and market coverage
Life Sciences and Healthcare
Telemedicine in Italy takes next step following pandemic regulatory advance
The 'care relationship' between the physician and the patient will be transformed by telemedicine if not superseded
Corporate
2023 predictions: What's on the horizon for US businesses operating in Europe?
By staying ahead of the curve and preparing for changes, US businesses can remain competitive and successful in Europe
Life Sciences and Healthcare
Pharma industry watches as UK Court of Appeal considers issue of plausibility
Decisions to invalidate blood clot drug patents are appealed
Life Sciences and Healthcare
New year brings healthcare professional interaction rule update in Belgium
The new rules offer more flexibility to life sciences businesses interacting with health professionals and organisations
Life Sciences and Healthcare
Products without an intended medical purpose: EU clarifies conditions
Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations
Life Sciences and Healthcare
The UK Patents Court puts an arrow through Teva's application for declaratory relief
Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions
Intellectual property
Could international and European legal obstacles jeopardise the German government's legislative plan to legalise cannabis?
German government publishes paper with legislative proposals, but the impact of international and European law on its plan is still
Life Sciences and Healthcare
Regulatory Horizons Council makes recommendations to UK government for the regulation of AI as a medical device
'Urgent need to get the regulation right' says RHC report which recommends an increase in regulatory capacity and capability to
Regulatory Outlook
Products | UK Regulatory Outlook November 2022
Government further delays use of UK product safety marking | UK-wide packaging regulations expected to enter into force in late
Intellectual property
Remanufacturing: How to define it and what its legal challenges are
Remanufacturing – the reprocessing of products – has long been considered a niche topic. This is currently changing. More and
